NeuroOne Medical Technologies Corporation
NMTC
$0.6043
$0.04237.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.68% | 234.92% | -63.29% | 31.10% | 195.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.68% | 234.92% | -63.29% | 31.10% | 195.43% |
| Cost of Revenue | -36.97% | 14.80% | -46.52% | -23.67% | -50.34% |
| Gross Profit | 128.11% | 162.01% | 38.66% | 44.60% | 118.75% |
| SG&A Expenses | -3.12% | -5.98% | 16.80% | 1.00% | 9.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.62% | -64.22% | -20.93% | -12.57% | 7.60% |
| Operating Income | 7.14% | 150.47% | 11.00% | 20.41% | 17.44% |
| Income Before Tax | 20.47% | 153.37% | -6.87% | 20.22% | 18.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.47% | 153.37% | -6.87% | 20.22% | 18.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.47% | 153.37% | -6.87% | 20.22% | 18.95% |
| EBIT | 7.14% | 150.47% | 11.00% | 20.41% | 17.44% |
| EBITDA | 7.46% | 153.31% | 11.27% | 20.92% | 18.16% |
| EPS Basic | 33.76% | 141.54% | 20.17% | 48.71% | 48.65% |
| Normalized Basic EPS | 22.35% | 141.56% | 21.83% | 48.74% | 47.24% |
| EPS Diluted | 33.76% | 141.36% | 20.17% | 48.71% | 48.65% |
| Normalized Diluted EPS | 22.35% | 141.45% | 21.83% | 48.74% | 47.24% |
| Average Basic Shares Outstanding | 20.07% | 28.51% | 33.90% | 55.60% | 57.85% |
| Average Diluted Shares Outstanding | 20.07% | 28.69% | 33.90% | 55.60% | 57.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |